Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

Affiliations

Comment

Alexandre R Zlotta et al. Nat Clin Pract Urol. 2006 Sep.

. 2006 Sep;3(9):474-5.

doi: 10.1038/ncpuro0579.

¹ Department of Urology at the University Clinics of Brussels in Brussels, Belgium. azlotta@ulb.ac.be

No abstract available

Comment on

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.
Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, Loidl W, Isorna S, Sundaram SK, Debois M, Collette L. Studer UE, et al. J Clin Oncol. 2006 Apr 20;24(12):1868-76. doi: 10.1200/JCO.2005.04.7423. J Clin Oncol. 2006. PMID: 16622261 Clinical Trial.